EFTR
Income statement / Annual
Last year (2023), eFFECTOR Therapeutics, Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, eFFECTOR Therapeutics, Inc.'s net income was -$35.81 M.
See eFFECTOR Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00 |
$3.55 M |
$1.43 M |
$42.00 M |
$0.00 |
| Cost of Revenue |
$111,000.00
|
$53,000.00
|
$24,000.00
|
$21.83 M
|
$307,000.00
|
| Gross Profit |
-$22.92 M
|
$3.50 M
|
$1.41 M
|
$20.17 M
|
-$307,000.00
|
| Gross Profit Ratio |
0
|
0.99
|
0.98
|
0.48
|
0
|
| Research and Development Expenses |
$22.92 M
|
$23.31 M
|
$19.96 M
|
$21.83 M
|
$23.58 M
|
| General & Administrative Expenses |
$10.93 M
|
$12.64 M
|
$13.37 M
|
$4.35 M
|
$4.72 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$10.93 M
|
$12.64 M
|
$13.37 M
|
$4.35 M
|
$4.72 M
|
| Other Expenses |
$0.00
|
-$3.55 M
|
-$1.43 M
|
$9,000.00
|
$0.00
|
| Operating Expenses |
$33.84 M
|
$32.40 M
|
$31.90 M
|
$26.18 M
|
$28.30 M
|
| Cost And Expenses |
$33.84 M
|
$32.40 M
|
$31.90 M
|
$26.18 M
|
$28.61 M
|
| Interest Income |
$1.95 M
|
$439,000.00
|
$6,000.00
|
$67,000.00
|
$239,000.00
|
| Interest Expense |
$0.00
|
$2.25 M
|
$1.76 M
|
$1.33 M
|
$1.38 M
|
| Depreciation & Amortization |
$111,000.00
|
$53,000.00
|
$24,000.00
|
$160,000.00
|
$307,000.00
|
| EBITDA |
-$33.73 M |
-$32.40 M |
-$31.90 M |
$16.06 M |
-$28.30 M |
| EBITDA Ratio |
0
|
-9.12
|
-22.31
|
0.38
|
0
|
| Operating Income Ratio |
0
|
-9.12
|
-22.31
|
0.38
|
0
|
| Total Other Income/Expenses Net |
-$1.97 M
|
$9.74 M
|
$47.70 M
|
-$1.26 M
|
-$1.13 M
|
| Income Before Tax |
-$35.81 M
|
-$22.67 M
|
$15.80 M
|
$14.56 M
|
-$29.74 M
|
| Income Before Tax Ratio |
0
|
-6.38
|
11.05
|
0.35
|
0
|
| Income Tax Expense |
$0.00
|
-$9.74 M
|
-$24,000.00
|
$351,000.00
|
$135,140.00
|
| Net Income |
-$35.81 M
|
-$12.93 M
|
$15.80 M
|
$14.21 M
|
-$29.74 M
|
| Net Income Ratio |
0
|
-3.64
|
11.05
|
0.34
|
0
|
| EPS |
-16.37 |
-7.85 |
9.78 |
23.74 |
-53.83 |
| EPS Diluted |
-16.37 |
-7.85 |
9.78 |
23.74 |
-53.83 |
| Weighted Average Shares Out |
$2.19 M
|
$1.65 M
|
$1.62 M
|
$598,559.00
|
$552,432.00
|
| Weighted Average Shares Out Diluted |
$2.19 M
|
$1.65 M
|
$1.62 M
|
$598,559.00
|
$552,432.00
|
| Link |
|
|
|
|
|
